Low-dose valganciclovir prophylaxis is safe and cost-saving in cmv-seropositive kidney transplant recipients
Introduction: Observational studies suggest that low-dose valganciclovir prophylaxis (450
mg daily for normal renal function) is as effective as and perhaps safer than standard-dose …
mg daily for normal renal function) is as effective as and perhaps safer than standard-dose …
Treatment of cytomegalovirus anterior uveitis at a North American tertiary center with oral valganciclovir
T Bhoopat, JS Takhar, CE Oldenburg, JD Keenan… - Cornea, 2020 - journals.lww.com
Purpose: Cytomegalovirus is an increasingly recognized cause of anterior uveitis. We
present clinical features of cytomegalovirus anterior uveitis (CMVAU) and outcomes of oral …
present clinical features of cytomegalovirus anterior uveitis (CMVAU) and outcomes of oral …
Multiple Anterior Chamber Paracenteses May Be Needed to Identify Cytomegalovirus Anterior Uveitis
C Benador-Shen, J Shantha, J Lee, Y Qian… - American Journal of …, 2025 - Elsevier
Purpose To demonstrate cases of anterior uveitis requiring more than one anterior chamber
paracenesis to elucidate CMV as the causative etiology. Design Retrospective chart review …
paracenesis to elucidate CMV as the causative etiology. Design Retrospective chart review …
Reduced dosing versus full dosing valganciclovir for prophylaxis of cytomegalovirus in high‐risk abdominal transplant recipients
ML Kreiser, R Dupuis, KR Szempruch… - Clinical …, 2023 - Wiley Online Library
Background Cytomegalovirus (CMV) is a common infection in abdominal transplant
recipients (ATR). Prevention of CMV in the highest risk population (CMV IgG …
recipients (ATR). Prevention of CMV in the highest risk population (CMV IgG …
Transplante renal, infecções associadas e suas medidas terapêuticas: uma revisão de literatura
PVDH Sarmento, A de Jesus Oliveira… - Revista Eletrônica …, 2022 - acervomais.com.br
Objetivo: Analisar o padrão de infecções relacionadas a receptores de transplante renal,
relacionando com possíveis métodos terapêuticos. Avaliando, assim, a relevância do …
relacionando com possíveis métodos terapêuticos. Avaliando, assim, a relevância do …
Efficacy and safety of low-dose valganciclovir prophylaxis among renal transplant recipients
İ Ergun - Cukurova Medical Journal, 2020 - dergipark.org.tr
Purpose: Cytomegalovirus (CMV) infection is one of the most common infections observed
following kidney transplantations. Transplantations between cytomegalovirus …
following kidney transplantations. Transplantations between cytomegalovirus …
Efficacy of short term valganciclovir in a standard-dose for cytomegalovirus prophylaxis in living donor kidney transplantation: a single-center report
G Ertugrul, T Yanaral - Ukrainian Journal of Nephrology and Dialysis, 2019 - ukrjnd.com.ua
Ukrainian Journal of Nephrology and Dialysis Page 1 22 Український журнал нефрології та
діалізу №3 (63) 2019 Ukrainian Journal of Nephrology and Dialysis, 3 (63)’2019 Випадки з …
діалізу №3 (63) 2019 Ukrainian Journal of Nephrology and Dialysis, 3 (63)’2019 Випадки з …
Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients
RWM Vernooij, M Michael, M Ladhani… - Cochrane Database …, 2024 - cochranelibrary.com
Background The risk of cytomegalovirus (CMV) infection in solid organ transplant recipients
has resulted in the frequent use of prophylaxis to prevent the clinical syndrome associated …
has resulted in the frequent use of prophylaxis to prevent the clinical syndrome associated …